# Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III

Study · id `cardio:ct-nct05141305` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05141305](<https://clinicaltrials.gov/study/NCT05141305>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05141305

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 516 participants.

## Technical summary

Registry record NCT05141305. Randomized; single masking; primary purpose treatment. Start 2022-01-19 (actual); primary completion 2024-01-29 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 516 participants (enrolled count; ClinicalTrials.gov record NCT05141305, source copy `cardio:ctgov-nct05141305-2024-04-30`, retrieved 2026-10-26)
- Started: 2022-01-19 (actual) (ClinicalTrials.gov record NCT05141305, source copy `cardio:ctgov-nct05141305-2024-04-30`, retrieved 2026-10-26)
- Primary completion: 2024-01-29 (actual) (ClinicalTrials.gov record NCT05141305, source copy `cardio:ctgov-nct05141305-2024-04-30`, retrieved 2026-10-26)
- Completion: 2024-02-09 (actual) (ClinicalTrials.gov record NCT05141305, source copy `cardio:ctgov-nct05141305-2024-04-30`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05141305, source copy `cardio:ctgov-nct05141305-2024-04-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05141305-2024-04-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III
- Acronym: TRACE III
- Condition: Ischemic Stroke, Acute
- Intervention (Drug): tenecteplase (0.25 mg/kg, Max 25 mg)
- Intervention (Drug): standard medical treatment
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention is a member of this class by a sourced record link: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy (`cardio:pubmed-38884324`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Clinical benefit of tenecteplase despite failed recanalization in late-window ischemic stroke: a post hoc analysis of the TRACE-3 trial (`cardio:pubmed-41992212`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0e91bc5683a329424b112826502725fcf8adc7fe82a1432af4795b4385252c79
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
